SUSQUEHANNA INTERNATIONAL GROUP, LLP - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$68,600
-61.0%
98,000
-49.8%
0.00%
Q4 2022$175,698
-19.0%
195,219
+438.5%
0.00%
Q3 2022$217,000
-30.2%
36,250
-55.7%
0.00%
Q1 2022$311,000
-64.0%
81,739
-57.4%
0.00%
Q4 2021$864,000
+94.6%
192,012
+101.6%
0.00%
Q3 2021$444,000
+0.5%
95,235
+51.7%
0.00%
Q2 2021$442,000
+100.9%
62,792
+720.8%
0.00%
Q2 2020$220,0007,6500.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders